CSBR vs PEAK
Champions Oncology Inc (CSBR) versus PEAK (PEAK) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
PEAK (PEAK) common stock.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
PEAK does not have a complete income-statement cache yet.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Not investment advice. Open the CSBR and PEAK stock pages for the full models.
Not investment advice.